title: Reliability of Japanese clinical trials estimated from GCP audit findings.
abstract: To describe the reliability of Japanese clinical trials, we compared the results of a Good Clinical Practice (GCP) audit conducted between April 1997 and March 2000 (fiscal year (FY) 1997 - 1999) with those from April 2004 - March 2005 (FY2004). The number and proportion of various types of deficiencies described in GCP audit reports were compared between the 2 periods. The audit findings in the former period were based on official audits that covered 331 hospitals and 775 trials. The audits in the latter period targeted 114 hospitals and 189 trials. The inspection of former period was undertaken by the Organization for Pharmaceuticals Safety and Research (OPSR). On the other hand, the latter period was undertaken by the Pharmaceuticals and Medical Devices Agency (PMDA). The total number of deficiencies detected in GCP audits was 1,529 in the former 3-year period (FY1997 - 1999) and 819 in the latter period (FY2004). The total number of deficiencies detected and reported was more than 1.5-fold on an annual basis in the latter period. By category of deficiencies, the proportion of protocol deviations increased from 14.7 (225/1,529) to 45.7% (374/819), while the proportion of errors in case report forms (CRFs) decreased from 43.6 (666/ 1,529) to 27.1% (222/819). There were two remarkable changes in audit findings between FY1997 - 1999 and FY2004; the increase in the proportion of protocol deviations and the decrease in the proportion of CRF-related deficiencies. We think that in Japan the improvement of research environments is needed to provide reliable clinical data responsible for the regulatory standard of GCP.
authors.affiliation: Department of Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Ishikawa, Japan. k-saito@hokuriku-u.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Saito
authors.forename: Y
authors.initials: Y
authors.lastname: Kodama
authors.forename: S
authors.initials: S
authors.lastname: Ono
authors.forename: C
authors.initials: C
authors.lastname: Maida
authors.forename: A
authors.initials: A
authors.lastname: Fujimura
authors.forename: E
authors.initials: E
authors.lastname: Miyamoto
mesh_terms: D002986:Clinical Trials as Topic / Q000592:standards* / Q000639:trends; D017408:Guidelines as Topic; D006761:Hospitals; D006801:Humans; D007564:Japan; D008485:Medical Audit; D011786:Quality Control; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards* / Q000639:trends; D013997:Time Factors